The activities of liver adenosine deaminase,xanthine oxidase,catalase,superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester
Restricted accessResearch articleFirst published online February, 2005
The activities of liver adenosine deaminase,xanthine oxidase,catalase,superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester
The aim of this experimental study was to investigate the effects of caffeic acid phenethyl ester (CAPE), an antioxidant agent, on cisplatin-induced hepatotoxicity through adenosine deaminase (AD), xanthine oxidase (XO), catalase (CAT), superoxide dismutase (SOD) activities and malondialdehyde (MDA) and nitric oxide (NO) levels in liver tissue of rats. Wistar albino rats were divided into three groups: control group (n-6), cisplatin group (n-9) and CAPE+cisplatin group (n-8). All the chemicals used were applied intraperitoneally. Spectrophotometric methods were used to determine the activities of the above-mentioned enzymes in the liver tissue. NO level and XO activity were found to be increased in the cisplatin group compared to the control group. NO level was found to be decreased in the cisplatin+CAPE group in comparison with the cisplatin group. There was no significant change in the activity of XO between the cisplatin and cisplatin+CAPE groups. The activity of SOD was lower in the cisplatin group than both the control and cisplatin+CAPE groups. There was no significant change in the activity of CAT between the control and cisplatin groups. CAT activity was increased in the cisplatin+CAPE group compared to the cisplatin group. The AD activity and MDA level remained unchanged in all groups. The results obtained suggested that CAPE significantly attenuated the hepatotoxicity as an indirect target of cisplatin in an animal model of cisplatin-induced nephrotoxicity.
Aebi, H.1974: Catalase. In Bergmeyer, H. U., editor, Methods of enzymatic analysis. New York and London: Academic Press, 673-677.
2.
Baliga, R., Zhang, Z., Baliga, M.et al.1998: In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney International53, 394-401.
3.
Cavalli, F., Tschopp, L., Sonntag, R. W. and Zimmermann, A.1978: A case of liver toxicity following cis-dichlorodiammineplatinum(II) treatment. Cancer Treatment Reports62, 2125-2126.
4.
Cersosimo, R. J.1993: Hepatotoxicity associated with cisplatin chemotherapy. Annals of Pharmacotherapy27, 438-441.
5.
Cortas, N. K. and Wakid, N. W.1990: Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clinical Chemistry36, 1440-1443.
6.
Draper, H. H. and Hadley, M.1990: Malondialdehyde determination as index of lipid peroxidation. Methods Enzymology186, 421-431.
7.
Durak, I., Yurtarslani, Z., Canbolat, O. and Akyol, O.1993: A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clinica Chimica Acta214, 103-104.
8.
Fadillioglu, E., Oztas, E., Erdogan, H.et al.2004: Protective effects of caffeic acid Phenethyl ester on doxorubicin-induced cardiotoxicity in rats. Journal of Applied Toxicology24, 47-52.
9.
Frenkel, K., Wei, H., Bhimani, R.et al.1993: Inhibition of tumor promoter-mediated processes in mouse skin and bovine lens by caffeic acid phenethyl ester. Cancer Research53, 1255-1261.
10.
Giusti, G.1974: Adenosine deaminase. In Bergmeyer, M. V., editor, Methods of enzymatic analysis, second edition. New York: Academic Press, 1092-1098.
11.
Grunberger, D., Banerjee, R., Eisinger, K.et al.1988: Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia44, 230-232.
12.
Hepsen, I. F., Er, H. and Cekic, O.1999: Topically applied water extract of propolis to suppress corneal neovascularization in rabbits. Ophthalmic Research31, 426-431.
13.
Hesketh, M. A., Twaddell, T. and Finn, A.1990: A possible role for cisplatin (DDP) in the transient hepatic enzyme elevations noted after ondansetron administration. Proceedings of the American Association for Clinical Oncology9, 323-323.
14.
Ilhan, A., Koltuksu, U., Ozen, S.et al.1999: The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits. European Journal of Cardio-thoracic Surgery16, 458-463.
15.
Irmak, M. K., Fadillioglu, E., Gulec, M.et al.2002: Effects of electromagnetic radiation from a cellular telephone on the oxidant and antioxidant levels in rabbits. Cell Biochemistry and Function20, 279-283.
16.
Khayyal, M. T., el-Ghazaly, M. A. and el-Khatib, A. S.1993: Mechanisms involved in the antiinflammatory effect of propolis extract. Drugs Under Experimental and Clinical Research19, 197-203.
17.
Kim, S. H., Hong, K. O., Chung, W. Y.et al.2004: Abrogation of cisplatin-induced hepatotoxicity in mice by xanthorrhizol is related to its effect on the regulation of gene transcription. Toxicology and Applied Pharmacology196, 346-355.
Liu, J., Liu, Y., Habeebu, S. S. M. and Klassen, C. D.1998: Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity. Toxicology and Applied Pharmacology149, 24-31.
20.
Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J.1951: Protein measurement with the folin phenol reagent. The Journal of Biological Chemistry193, 265-275.
21.
Madias, N. E. and Harrington, J. T.1978: Platinum nephrotoxi-city. The American Journal of Medicine65, 307-314.
22.
Mansour, M. A., Mostafa, A. M., Nagi, M. N.et al.2002: Protective effect of aminoguanidine against nephrotoxicity induced by cisplatin in normal rats. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology132, 123-128.
23.
Masuda, H., Tanaka, T. and Takahama, U.1994: Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochemical and Biophysical Research Communications203, 1175-1180.
24.
Matsushima, H., Yonemura, K., Ohishi, K. and Hishida, A.1998: The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. The Journal of Laboratory and Clinical Medicine131, 518-526.
25.
Mollman, J. E., Glover, D. J., Hogan, W. M. and Furman, R. E.1988: Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721. Cancer61, 2192-2195.
26.
Naziroglu, M., Karaoglu, A. and Aksoy, A. O.2004: Selenium and high dose vitamine E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology195, 221-230.
27.
Ozen, S., Akyol, O., Iraz, M.et al.2004: Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats. Journal of Applied Toxicology24, 27-35.
28.
Ozyurt, H., Sogut, S., Yildirim, Z.et al.2004: Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats. Clinica Chimica Acta339, 65-75.
29.
Peresleni, T., Noiri, E., Bahou, W. F. and Goligorsky, M. S.1996: Antisense oligodeoxynucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury. The American Journal of Physiology270, F971-F977.
30.
Prajda, N. and Weber, G.1975: Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Letters59, 245-249.
31.
Rosenberg, B.1977: Noble metal complexes in cancer chemotherapy. Advances in Experimental Medicine and Biology91, 129-150.
32.
Scapagnini, G., Foresti, R., Calabrese, V.et al.2002: Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1inducers. MolecularPharmacology61, 554-561.
33.
Sogut, S., Zoroglu, S. S., Ozyurt, H.et al.2003: Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clinica Chimica Acta331, 111-117.
34.
Sogut, S., Kotuk, M., Yilmaz, H. R.et al.2004: In vivo evidence suggestion a role for purine catabolizing enzymes in pathogenesis of cisplatin-induced nephrotoxicity in rats and effect of erdosteine against this toxicity. Cell Biochemistry and Function22, 157-162.
35.
Song, Y. S., Park, E. H., Hur, G. M.et al.2002: Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity. Cancer Letters175, 53-61.
36.
Sud’ina, G. F., Mirzoeva, O. K., Pushkareva, M. A.et al.1993: Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Letters329, 21-24.
37.
Sun, Y., Oberley, L. W. and Li, Y.1988: A simple method for clinical assay of superoxide dismutase. Clinical Chemistry34, 497-500.
38.
Uz, E., Sogut, S., Sahin, S.et al.2002: The protective role of caffeic acid phenethyl ester (CAPE) on testicular tissue after testicular torsion and detorsion. World Journal of Urology20, 264-270.
39.
Van Basten, J. P., Schafford-Koops, H., Sleijfer, D. T.et al.1997: Current concept about testicular cancer. The European Journal of Surgery23, 354-360.
40.
Vermorken, J. B. and Pinedo, H. M.1982: Gastrointestinal toxicity of cis -diammine-dichloroplatinum(II). The Netherlands Journal of Medicine25, 270-274.
41.
Von Hoff, D. D., Schilsky, R., Reichert, C. M.et al.1979: Toxic effects of cis-dichlorodiammineplatinum(II) in man. Cancer Treatment Reports63, 1527-1531.
Zicca, A., Cafaggi, S., Mariggio, M. A.et al.2002: Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats. European Journal of Pharmacology442, 265-272.
